
Dabigo 150mg Capsule
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Dabigatran Etexilate (150mg)
Overview Dabigo 150mg Capsule
Betrixaban 150mg capsules are prescribed as a blood thinner, preventing and treating blood clots. This medication lowers the risk of stroke and heart attack, and inhibits clot formation in leg, lung, brain, and heart veins. Frequently used for patients with atrial fibrillation (irregular heartbeat), it also reduces post-surgical clotting risks following knee or hip replacements. Dosage can be taken with or without food, but consistent daily timing is recommended. Long-term or lifelong use may be necessary; discontinuation or dosage changes require physician consultation to avoid increased stroke, heart attack, or thrombosis risk. Lifestyle modifications – such as healthy eating, exercise, weight management, and smoking cessation – further reduce clot risk. Common side effects include gastrointestinal discomfort and increased bleeding susceptibility (e.g., nosebleeds, bruising). Report any adverse effects immediately to your doctor. Other potential side effects encompass headaches, seizures, allergic reactions, visual disturbances, and fatigue. Contraindications include severe hepatic or renal impairment, active bleeding, and concurrent use of other anticoagulants. Breastfeeding is not recommended during treatment. Unlike certain other anticoagulants, routine PT-INR monitoring is unnecessary.
Primary Ingredients of Dabigo 150mg Capsule
No text provided. Please provide the text you wish me to rephrase.
Uses of Dabigo 150mg Capsule
Managing and averting blood clot formation
Major Benefits of Dabigo 150mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dabigo 150mg Capsules can be ingested with or without food; however, consistent daily timing is recommended.
Common Side effects of Dabigo 150mg Capsule:
- Nausea
- Anemia (low number of red blood cells)
- Gastrointestinal bleeding
- Dyspepsia
- Diarrhea
- Abdominal pain
- Nosebleeds
- Skin bleeding
How to use Dabigo 150mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Dabigo 150mg Capsules. These capsules can be ingested with or without food, though consistent timing is recommended.
How Dabigo 150mg Capsule works:
Apixaban 150mg capsules represent a new class of oral blood thinners. Their mechanism of action involves inhibiting clot development within the circulatory system.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dabigo 150mg Capsules with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dabigo 150mg capsules during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice before taking Dabigo during pregnancy.
Breast feedingCONSULT YOUR DOCTOR
Use of Dabigo 150mg capsules while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Dabigo 150mg capsules.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Dabigo 150mg capsules, as dose modification may be necessary. A physician's consultation is advised. Dabigo 150mg capsules are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when taking Dabigo 150mg capsules. Dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Dabigo 150mg Capsule :
Should you forget a Dabigo 150mg Capsule dose, ingest it immediately if still within the same day. However, omit the missed dose if ingestion is impossible at least six hours prior to your next scheduled dose. Never compensate for a missed dose by taking two capsules at once.
Facts to Know About Dabigo 150mg Capsule
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole-based compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | Oral direct thrombin inhibitor |
